- Home
- KYTX vs CAPN Comparison
KYTX vs CAPN Comparison
Compare KYTX & CAPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KYTX
- CAPN
- Stock Information
- Founded
- KYTX 2018
- CAPN 2024
- Country
- KYTX United States
- CAPN United States
- Employees
- KYTX N/A
- CAPN N/A
- Industry
- KYTX
- CAPN
- Sector
- KYTX
- CAPN
- Exchange
- KYTX NYSE
- CAPN NYSE
- Market Cap
- KYTX 92.1M
- CAPN 74.6M
- IPO Year
- KYTX 2024
- CAPN 2024
- Fundamental
- Price
- KYTX $2.55
- CAPN $10.24
- Analyst Decision
- KYTX Strong Buy
- CAPN
- Analyst Count
- KYTX 5
- CAPN 0
- Target Price
- KYTX $19.00
- CAPN N/A
- AVG Volume (30 Days)
- KYTX 382.4K
- CAPN 776.0
- Earning Date
- KYTX 05-13-2025
- CAPN 01-01-0001
- Dividend Yield
- KYTX N/A
- CAPN N/A
- EPS Growth
- KYTX N/A
- CAPN N/A
- EPS
- KYTX N/A
- CAPN N/A
- Revenue
- KYTX N/A
- CAPN N/A
- Revenue This Year
- KYTX N/A
- CAPN N/A
- Revenue Next Year
- KYTX N/A
- CAPN N/A
- P/E Ratio
- KYTX N/A
- CAPN $98.36
- Revenue Growth
- KYTX N/A
- CAPN N/A
- 52 Week Low
- KYTX $1.78
- CAPN $9.95
- 52 Week High
- KYTX $16.64
- CAPN $10.47
- Technical
- Relative Strength Index (RSI)
- KYTX 57.07
- CAPN N/A
- Support Level
- KYTX $2.43
- CAPN N/A
- Resistance Level
- KYTX $2.82
- CAPN N/A
- Average True Range (ATR)
- KYTX 0.23
- CAPN 0.00
- MACD
- KYTX 0.04
- CAPN 0.00
- Stochastic Oscillator
- KYTX 64.47
- CAPN 0.00
About KYTX KYVERNA THERAPEUTICS INC
Kyverna Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on developing cell therapies for patients suffering from autoimmune diseases. Its product, KYV-101, is an autologous CD19 CAR T-cell product candidate made from an underlying chimeric antigen receptor, or CAR. It is also developing KYV-201, an allogeneic therapy containing the same CAR as KYV-101, to develop it in multiple autoimmune diseases.
About CAPN CAYSON ACQUISITION CORP
Cayson Acquisition Corp is a blank check company.